Moleculin to Report Full Year 2022 Financial Results on March 22, 2023 and Host Conference Call and Webcast

/PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a growing pipeline,...

Related Keywords

Houston ,Texas ,United States ,John Paul Waymack ,Jonathan Foster ,Jenene Thomas ,Walter Klemp ,Moleculin Biotech Inc ,Linkedin ,Twitter ,Prnewswire Moleculin Biotech Inc ,Facebook ,Nasdaq ,Chief Executive Officer ,Senior Chief Medical Officer ,Moleculin Biotech Conference ,Moleculin Biotech ,Transcription Modulator ,Nc ,